2010/10/01
Blood test developed for non-alcoholic fatty liver disease diagnosis
Researchers from the Metabolomics unit at CICbioGUNE-CIBERehd and OWL Genomics Ltd. (Bilbao, Spain) have used metabolomics technology to develop a blood test for non-alcoholic fatty liver disease (NAFLD) diagnosis. This research has been recently published in The Journal of Proteome Research. OWL Genomics Ltd. is beginning to commercialize this new test in Spain.